34.75 -1.80 (-4.92%)

New 52W High in past week

55,020 BSE Volume

BSE Jun 27, 2022 04:01 PM



Get corporate announcements alerts
Indrayani Biotech Ltd.    
02 Jun 2022
34.75
-4.92%
INDRAYANI BIOTECH LTD. - 526445 - Intimation With Respect To Conversion Of Our Wholly Owned Subsidiary …
BSE India
We have been informed by our wholly owned subsidiaries of that pursuant to conversion of its status from private limited company to public limited company, its name has been changed from: 1. 'IBL Healthcare Private Limited' to 'IBL Healthcare Limited' 2. 'HSL Agri Solutions Private Limited' to 'HSL Agri Solutions Limited'. Please find enclosed herewith the attachment pertaining to the same for your records
Indrayani Biotech Ltd.    
01 Jun 2022
34.75
-4.92%
INDRAYANI BIOTECH LTD. - 526445 - Announcement under Regulation 30 (LODR)-Newspaper Publication
BSE India
Pursuant to the Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed herewith the copy of newspaper publications pertaining to Audited Financial Results for the quarter and year ended 31st March, 2022 published in Trinity Mirror in English Language and Makkal Kural in Tamil Language on 1st June 2022.
Indrayani Biotech Ltd.    
30 May 2022
34.75
-4.92%
INDRAYANI BIOTECH LTD. - 526445 - Audited Standalone & Consolidated Financial Results For The Quarter And …
BSE India
The Board of Directors at its meeting held today, viz. May 30, 2022, has considered and approved the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2022. A copy of duly signed audited financial results along with audit reports and declaration in respect of audit report with unmodified opinion under Regulation 33 of Listing Regulations, is enclosed. The meeting of the Board of Directors commenced at 9.00 p.m. and concluded at 10.00 p.m. Kindly take the aforesaid information on your records.
default
Indrayani Biotech Ltd.    
30 May 2022
34.75
-4.92%
INDRAYANI BIOTECH LTD. - 526445 - Board Meeting Outcome for Audited Financial Results For The Quarter …
BSE India
The Board of Directors at its meeting held today, viz. May 30, 2022, has considered and approved the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2022. A copy of duly signed audited financial results along with audit reports and declaration in respect of audit report with unmodified opinion under Regulation 33 of Listing Regulations, is enclosed. The meeting of the Board of Directors commenced at 9.00 p.m. and concluded at 10.00 p.m. Kindly take the aforesaid information on your records.
Indrayani Biotech Ltd.    
30 May 2022
34.75
-4.92%
Indrayani Biotech Ltd.    
25 May 2022, 05:58PM
34.75
-4.92%
INDRAYANI BIOTECH LTD. - 526445 - Update On Incorporation Of A Wholly Owned Subsidiary Company.
BSE India
This is further to our intimation dated 14th November 2021, pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, relating to incorporation of a wholly owned subsidiary of Indrayani Biotech Limited. Further to the above intimation, a wholly owned subsidiary company in the name and style of 'IBL Investments Limited' has been incorporated on 24th May 2022 with CIN: U65990TN2022PLC152486.
Indrayani Biotech Ltd.    
23 May 2022
34.75
-4.92%
Indrayani Biotech Ltd.    
19 May 2022
34.75
-4.92%
INDRAYANI BIOTECH LTD. - 526445 - Disclosure With Respect To Memorandum Of Understanding Entered Between Indrayani …
BSE India
This is to inform you that Indrayani Biotech Limited in line with the company's philosophy of aggregation and assimilation of suitable business to achieve vertical and inclusive growth, is in the process of associating with Dindigul Farm Product Private Limited. Please find attached herewith the disclosure with respect to MoU entered between Indrayani Biotech Limited and Dindigul Farm Product Private Limited.
Indrayani Biotech Ltd.    
19 May 2022
34.75
-4.92%
Indrayani Biotech Ltd.    
17 May 2022
34.75
-4.92%
8 Votes:
Buy 62.5%
Sell 12.5%
Hold 25.0%
BUY
SELL
HOLD